ESC Premium Access

Antiplatelet therapy in high bleeding risk patients with and without oral anticoagulant therapy after coronary stenting

Congress Presentation

About the speaker

Doctor Pieter C Smits

Maasstad Hospital, Rotterdam (Netherlands (The))
4 presentations
0 follower

2 more presentations in this session

SYNTAX II trial: five year follow-up

Speaker: Professor A. Banning (Oxford, GB)

Thumbnail

TWILIGHT-HBR: Ticagrelor Monotherapy in High Bleeding Risk Patients

Speaker: Doctor D. Cao (Bergamo, IT)

Thumbnail

Access the full session

Trial Updates in ACS & PCI

Speakers: Doctor P. Smits, Professor A. Banning, Doctor D. Cao
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

EHRA Premium Access

Hot topics in atrial fibrillation.

5 April 2022

ESC Premium Access

Choosing wisely: ablation or medication for rhythm control in atrial fibrillation – discussion.

27 August 2021

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

ESC 365 is supported by

logo Novo Nordisk